Hidden virus danger for cancer patients?
NCT ID NCT06347588
Summary
This study aims to understand the risk of a hidden hepatitis B virus reactivating in cancer patients receiving immunotherapy. Researchers will observe 60 patients who have cancer and evidence of a past hepatitis B infection but no active virus. The goal is to learn how often the virus becomes active again during cancer treatment to help guide future patient care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCCULT HEPATITIS B INFECTION IN CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Irccs San Matteo Pavia
Pavia, PV, 27100, Italy
Conditions
Explore the condition pages connected to this study.